FDA 483 - Hansen Mueller Company Kansas City - May 03, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Hansen Mueller Company Kansas City, a warehouse, revealed critical deficiencies in preventing cross-contamination between mammalian and non-mammalian derived protein products. The firm failed to implement adequate cleanout procedures, properly label products with required caution statements, and ensure employees were trained on product separation and BSE. Additionally, equipment was not cleaned and maintained to prevent contamination, with observed insect and mold buildup.
ID · e0bfc3db-f4c5-4e02-bf0a-599863b5ce97